Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

NT-3 Gene Therapy Improves Compound Muscle Action Potential (CMAP) and Function in Mouse Model for Charcot-Marie-Tooth (CMT) Neuropathy
Neurogenetics and Gene Therapy
(-)
005
Authors/Disclosures
Zarife F. Sahenk, MD, PhD, FÂé¶¹´«Ã½Ó³»­ (The Research Institute at Nationwide Childrens.org) Dr. Sahenk has nothing to disclose.
Gloria Galloway, MD, FÂé¶¹´«Ã½Ó³»­ No disclosure on file
Christopher Edwards (The Research Institute At Nationwide Children) No disclosure on file
John W. Cochran, MD No disclosure on file